Sign in
Explore the registryTrack Gsk3772701 600 mg's trials

A Phase 2A Study of a Novel Antimalarial Pyrrolidinamide in Adult Patients With Uncomplicated P. Falciparum Malaria

GSK3772701 600 mgOngoingNot yet recruitingPhase 2Open NCT07545681 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…